0001494650-24-000083.txt : 20240607
0001494650-24-000083.hdr.sgml : 20240607
20240607162343
ACCESSION NUMBER: 0001494650-24-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heyman Tomas J.
CENTRAL INDEX KEY: 0001814673
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38241
FILM NUMBER: 241029844
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OptiNose, Inc.
CENTRAL INDEX KEY: 0001494650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 421771610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 TOWNSHIP LINE ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
BUSINESS PHONE: 267-364-3500
MAIL ADDRESS:
STREET 1: 777 TOWNSHIP LINE ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
4
1
wk-form4_1717791814.xml
FORM 4
X0508
4
2024-06-06
0
0001494650
OptiNose, Inc.
OPTN
0001814673
Heyman Tomas J.
C/O OPTINOSE, INC.
777 TOWNSHIP LINE ROAD, SUITE 300
YARDLEY
PA
19067
1
0
0
0
0
Stock Option (Right to Buy)
1.04
2024-06-06
4
A
0
75000
0
A
2034-06-06
Common Stock
75000
75000
D
The option vests and becomes exercisable on the earlier of (i) June 6, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.
/s/ Anthony J. Krick, Attorney-in-Fact
2024-06-07